Pharmacists’ stigma toward patients engaged in opioid misuse: When “social distance” does not mean disease prevention

References

• American Psychiatric Association. Diagnostic and statistical manual of mental disorders, Fifth edition. https://www.appi.org/Diagnostic_and_Statistical_Manual_of_Mental_Disorders_DSM-5_Fifth_Edition. Accessed August 17, 2020.
   Google Scholar
• Key substance use and mental health indicators in the United States: results from the 2016 national survey on drug use and health | CBHSQ data. https://www.samhsa.gov/data/report/key-substance-use-and-mental-health-indicators-united-states-results-2016-national-survey. Accessed August 17, 2020.
   Google Scholar
• National Institute on Drug Abuse. Summary of misuse of prescription drugs. https://www.drugabuse.gov/publications/research-reports/misuse-prescription-drugs/overview. Accessed August 18, 2020.
   Google Scholar
• Webster LR, Webster RM. Predicting aberrant behaviors in opioid-treated patients: preliminary validation of the Opioid Risk Tool. Pain Med. 2005;6(6):432–442.
   PubMed Web of Science ®Google Scholar
• Bratberg JP, Smothers ZPW, Collins K, Erstad B, Veve JR, Muzyk AJ. Pharmacists and the opioid crisis: a narrative review of pharmacists’ practice roles. J Am Coll Clin Pharm. 2020;3(2):478–484.
   Google Scholar
• Skoy E, Eukel H, Werremeyer A, Strand M, Frenzel O, Steig J. Implementation of a statewide program within community pharmacies to prevent opioid misuse and accidental overdose. J Am Pharm Assoc. 2020;60(1):117–121.
   Google Scholar
• van Boekel LC, Brouwers EPM, van Weeghel J, Garretsen HFL. Stigma among health professionals towards patients with substance use disorders and its consequences for healthcare delivery: systematic review. Drug Alcohol Depend. 2013;131(1-2):23–35.
   PubMed Web of Science ®Google Scholar
• Link BG, Yang LH, Phelan JC, Collins PY. Measuring mental illness stigma. Schizophr Bull. 2004;30(3):511–541.
   PubMed Web of Science ®Google Scholar
• Brown SA. Standardized measures for substance use stigma. Drug Alcohol Depend. 2011;116(1–3):137–141.
   PubMed Web of Science ®Google Scholar
• Wark C, Galliher JF. Emory Bogardus and the origins of the SOCIAL Distance Scale. Am Soc. 2007;38(4):383–395.
   Google Scholar
• Phimarn W, Kaewphila P, Suttajit S, Saramunee K. Depression screening and advisory service provided by community pharmacist for depressive students in university. SpringerPlus. 2015;4(1):470.
   PubMedGoogle Scholar
• Pescosolido BA, Medina TR, Martin JK, Long JS. The “backbone” of stigma: identifying the global core of public prejudice associated with mental illness. Am J Public Health. 2013;103(5):853–860.
   PubMed Web of Science ®Google Scholar
• Lien Y-Y, Lin H-S, Tsai C-H, Lien Y-J, Wu T-T. Changes in attitudes toward mental illness in healthcare professionals and students. Int J Environ Res Public Health. 2019;16(23):4655.
   Web of Science ®Google Scholar
• Bahora M, Hanafi S, Chien VH, Compton MT. Preliminary evidence of effects of crisis intervention team training on self-efficacy and social distance. Adm Policy Ment Health. 2008;35(3):159–167.
   PubMed Web of Science ®Google Scholar
• Subramaniam M, Abdin E, Picco L, et al. Stigma towards people with mental disorders and its components – a perspective from multi-ethnic Singapore. Epidemiol Psychiatr Sci. 2017;26(4):371–382.
   PubMed Web of Science ®Google Scholar
• Tay S, Alcock K, Scior K. Mental health problems among clinical psychologists: stigma and its impact on disclosure and help-seeking. J Clin Psychol. 2018;74(9):1545–1555.
   PubMed Web of Science ®Google Scholar
• Ritsher JB, Phelan JC. Internalized stigma predicts erosion of morale among psychiatric outpatients. Psychiatry Res. 2004;129(3):257–265.
   PubMed Web of Science ®Google Scholar
• Thornicroft G. Premature death among people with mental illness. BMJ. 2013;346:f2969.
   PubMedGoogle Scholar
• Corrigan PW, Mittal D, Reaves CM, et al. Mental health stigma and primary health care decisions. Psychiatry Res. 2014;218(1–2):35–38.
   PubMed Web of Science ®Google Scholar
• O'Reilly CL, Bell JS, Kelly PJ, Chen TF. Exploring the relationship between mental health stigma, knowledge and provision of pharmacy services for consumers with schizophrenia. Res Soc Adm Pharm. 2015;11(3):e101–e109.
   PubMed Web of Science ®Google Scholar
• Cannon-Breland ML, Westrick SC, Kavookjian J, Berger BA, Shannon DM, Lorenz RA. Pharmacist self-reported antidepressant medication counseling. J Am Pharm Assoc. 2013;53(4):390–399.
   Google Scholar
• Watkins A, McKee J, Hughes C, Pfeiffenberger T. Community pharmacists' attitudes toward providing care and services to patients with severe and persistent mental illness. J Am Pharm Assoc. 2017;57(3S):S217–S224.e2.
   Google Scholar
• Schomerus G, Lucht M, Holzinger A, Matschinger H, Carta MG, Angermeyer MC. The stigma of alcohol dependence compared with other mental disorders: a review of population studies. Alcohol Alcohol. 2011;46(2):105–112.
   PubMed Web of Science ®Google Scholar
• Bakhireva LN, Bautista A, Cano S, Shrestha S, Bachyrycz AM, Cruz TH. Barriers and facilitators to dispensing of intranasal naloxone by pharmacists. Subst Abus. 2018;39(3):331–341.
   PubMed Web of Science ®Google Scholar
• CEImpact A. August 27, 2020. https://www.ceimpact.com/ Copyright 2020 CEImpact.
   Google Scholar
• McGinty EE, Goldman HH, Pescosolido B, Barry CL. Portraying mental illness and drug addiction as treatable health conditions: effects of a randomized experiment on stigma and discrimination. Soc Sci Med. 2015;126:73–85.
   PubMed Web of Science ®Google Scholar
• Penn DL, Guynan K, Daily T, Spaulding WD, Garbin CP, Sullivan M. Dispelling the stigma of schizophrenia: what sort of information is best? Schizophr Bull. 1994;20(3):567–578.
   PubMed Web of Science ®Google Scholar
• Eukel HN, Skoy E, Werremeyer A, Burck S, Strand M. Changes in pharmacists’ perceptions after a training in opioid misuse and accidental overdose prevention. J Contin Educ Health Prof. 2019;39(1):7–12.
   PubMed Web of Science ®Google Scholar
• Allen B, Harocopos A, Chernick R. Substance use stigma, primary care, and the new york state prescription drug monitoring program. Behav Med. 2020;46(1):52–62.
   PubMed Web of Science ®Google Scholar
• Smith JD, Mittal D, Chekuri L, Han X, Sullivan G. A comparison of provider attitudes toward serious mental illness across different health care disciplines. Stigma Health. 2017;2(4):327–337.
   Google Scholar
• Giannetti V, Caley CF, Kamal KM, et al. Community pharmacists and mental illness: a survey of service provision, stigma, attitudes and beliefs. Int J Clin Pharm. 2018;40(5):1096–1105.
   PubMed Web of Science ®Google Scholar
• Calogero S, Caley CF. Supporting patients with mental illness: deconstructing barriers to community pharmacist access. J Am Pharm Assoc. 2017;57(2):248–255.
   Google Scholar
• Knaak S, Mantler E, Szeto A. Mental illness-related stigma in healthcare: barriers to access and care and evidence-based solutions. Healthc Manage Forum. 2017;30(2):111–116.
   PubMedGoogle Scholar
• Unhjem JV, Hem MH, Vatne S. Encountering ambivalence – a qualitative study of mental health nurses' experiences with dual relationships. Issues Ment Health Nurs. 2018;39(6):457–466.
   PubMed Web of Science ®Google Scholar
• de Oliveira DR, Shoemaker SJ. Achieving patient centeredness in pharmacy practice: openness and the pharmacist's natural attitude. J Am Pharm Assoc. 2006;46(1):56–66.
   Google Scholar
• American Pharmacists Association. Code of Ethics. 1994. https://www.pharmacist.com/code-ethics. Accessed January 26, 2021.
   Google Scholar
• McCullough MB, Petrakis BA, Gillespie C, et al. Knowing the patient: A qualitative study on care-taking and the clinical pharmacist-patient relationship. Res Social Adm Pharm. 2016;12(1):78–90.
   PubMed Web of Science ®Google Scholar
• Worley-Louis MM, Schommer JC, Finnegan JR. Construct identification and measure development for investigating pharmacist-patient relationships. Patient Educ Couns. 2003;51(3):229–238.
   PubMed Web of Science ®Google Scholar
• Jorm AF, Oh E. Desire for social distance from people with mental disorders. Aust N Z J Psychiatry. 2009;43(3):183–200.
   PubMed Web of Science ®Google Scholar
• Schomerus G, Matschinger H, Angermeyer MC. Continuum beliefs and stigmatizing attitudes towards persons with schizophrenia, depression and alcohol dependence. Psychiatry Res. 2013;209(3):665–669.
   PubMed Web of Science ®Google Scholar
• Seaton V, Piel M. Student pharmacists' social distancing toward people with mental illness. Ment Health Clin. 2017;7(5):181–186.
   PubMedGoogle Scholar
• Lincoln TM, Arens E, Berger C, Rief W. Can antistigma campaigns be improved? A test of the impact of biogenetic vs. psychosocial causal explanations on implicit and explicit attitudes to schizophrenia. Schizophr Bull. 2008;34(5):984–994.
   PubMed Web of Science ®Google Scholar
• Kvaale EP, Haslam N, Gottdiener WH. The 'side effects' of medicalization: a meta-analytic review of how biogenetic explanations affect stigma. Clin Psychol Rev. 2013;33(6):782–794.
   PubMed Web of Science ®Google Scholar
• Larkings JS, Brown PM. Do biogenetic causal beliefs reduce mental illness stigma in people with mental illness and in mental health professionals? A systematic review. Int J Ment Health Nurs. 2018;27(3):928–941.
   PubMed Web of Science ®Google Scholar
• Gronholm PC, Henderson C, Deb T, Thornicroft G. Interventions to reduce discrimination and stigma: the state of the art. Soc Psychiatry Psychiatr Epidemiol. 2017;52(3):249–258.
   PubMed Web of Science ®Google Scholar
• Livingston JD, Milne T, Fang ML, Amari E. The effectiveness of interventions for reducing stigma related to substance use disorders: a systematic review. Addiction. 2012;107(1):39–50.
   PubMed Web of Science ®Google Scholar
• Stigma-reducing language. Shatterproof. https://www.shatterproof.org/about-addiction/stigma/stigma-reducing-language. Accessed August 28, 2020.
   Google Scholar
• Broyles LM, Binswanger IA, Jenkins JA, et al. Confronting inadvertent stigma and pejorative language in addiction scholarship: a recognition and response. Subst Abus. 2014;35(3):217–221.
   PubMed Web of Science ®Google Scholar
• Schnittker J. Gender and reactions to psychological problems: an examination of social tolerance and perceived dangerousness. J Health Soc Behav. 2000;41(2):224–240.
   Web of Science ®Google Scholar
• Thornicroft G, Mehta N, Clement S, et al. Evidence for effective interventions to reduce mental-health-related stigma and discrimination. The Lancet. 2016;387(10023):1123–1132.
   PubMed Web of Science ®Google Scholar
• Matheson C, Thiruvothiyur M, Robertson H, Bond C. Community pharmacy services for people with drug problems over two decades in Scotland: implications for future development. Int J Drug Policy. 2016;27:105–112.
   PubMed Web of Science ®Google Scholar